- Home
- DOMH vs EVOK Comparison
DOMH vs EVOK Comparison
Compare DOMH & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- EVOK
- Stock Information
- Founded
- DOMH 1967
- EVOK 2007
- Country
- DOMH United States
- EVOK United States
- Employees
- DOMH N/A
- EVOK N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- EVOK Health Care
- Exchange
- DOMH Nasdaq
- EVOK Nasdaq
- Market Cap
- DOMH 74.7M
- EVOK 4.2M
- IPO Year
- DOMH N/A
- EVOK 2013
- Fundamental
- Price
- DOMH $5.33
- EVOK $5.50
- Analyst Decision
- DOMH
- EVOK
- Analyst Count
- DOMH 0
- EVOK 0
- Target Price
- DOMH N/A
- EVOK N/A
- AVG Volume (30 Days)
- DOMH 278.7K
- EVOK 7.2M
- Earning Date
- DOMH 08-07-2025
- EVOK 08-12-2025
- Dividend Yield
- DOMH 6.41%
- EVOK N/A
- EPS Growth
- DOMH N/A
- EVOK N/A
- EPS
- DOMH N/A
- EVOK N/A
- Revenue
- DOMH $24,891,000.00
- EVOK $11,594,083.00
- Revenue This Year
- DOMH N/A
- EVOK $57.82
- Revenue Next Year
- DOMH N/A
- EVOK $59.12
- P/E Ratio
- DOMH N/A
- EVOK N/A
- Revenue Growth
- DOMH 630.80
- EVOK 89.89
- 52 Week Low
- DOMH $0.83
- EVOK $1.94
- 52 Week High
- DOMH $13.58
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- DOMH 44.76
- EVOK 74.84
- Support Level
- DOMH $4.94
- EVOK $2.52
- Resistance Level
- DOMH $5.21
- EVOK $9.88
- Average True Range (ATR)
- DOMH 0.40
- EVOK 0.49
- MACD
- DOMH -0.08
- EVOK 0.39
- Stochastic Oscillator
- DOMH 0.64
- EVOK 49.19
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.